🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06663969
Recruiting Not applicable

Evaluating Modulation Effects of Temporal Interference Using SEEG

NCT06663969 · tracked via the Priya Life Science China tracker
Sponsor
Xuanwu Hospital, Beijing
Phase
Not applicable
Started
2024-11-04
Last updated
2025-02-05

Condition(s) studied

Deep Brain StimulationDrug Resistant Epilepsy

Investigational drug(s) / intervention(s)

Temporal Interference

Temporal Interference: Researchers applied temporal interference (TI) stimulation to the deep brain nuclei of patients who had undergone SEEG monitoring, recording changes in electrical activity detected by SEEG.

Study summary

This single-center prospective study aims to investigate the electrophysiological mechanisms of temporal interference (TI) in humans by analyzing clinical, imaging, and electrophysiological data from patients aged 14-60 with drug-resistant epilepsy.

Eligibility

Sex
ALL
Min age
14 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of drug-resistant epilepsy; * No severe systemic diseases; * Implantation of stereotactic electrodes; * Agreement to participate in this study and signs the informed consent form. Exclusion Criteria: * Hematoma at the scalp electrode site or fluid accumulation under the electrode after intracranial electrode placement.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xuanwu Hospital,Capital Medical University Beijing Beijing Municipality Recruiting

More Xuanwu Hospital, Beijing trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06663969 on ClinicalTrials.gov ↗ ← All trials in China